ArticleCancers2021

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.